[Drug therapy of migraine and cluster headache].
D000700:Analgesics / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D002110:Caffeine / Q000009:adverse effects / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D004357:Drug Synergism; D004876:Ergot Alkaloids / Q000009:adverse effects / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D014653:Vascular Headaches / Q000188:drug therapy*
D000700:Analgesics; D001463:Barbiturates; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists; D002110:Caffeine; D004087:Dihydroergotamine; D008784:Methysergide
Die medikamentöse Therapie der Migräne und des Cluster-Kopfschmerzes